Financhill
Sell
35

KMT Quote, Financials, Valuation and Earnings

Last price:
$21.58
Seasonality move :
4.11%
Day range:
$21.30 - $21.67
52-week range:
$20.50 - $32.18
Dividend yield:
3.7%
P/E ratio:
17.73x
P/S ratio:
0.85x
P/B ratio:
1.37x
Volume:
3.1M
Avg. volume:
1.1M
1-year change:
-11.39%
Market cap:
$1.7B
Revenue:
$2B
EPS (TTM):
$1.22

Earnings Data

Next earnings date for KMT
May 08
2025
Most recent earnings per share
$0.23
Missed by $0.03
(Feb 5/2025)
Consensus Estimate
$0.26
(Feb 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KMT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $488.5M -- -- $0.25 --
02/05/2025 Q4 $487.6M $482.1M $0.23 $0.26 -$0.03
11/06/2024 Q3 $484.9M $481.9M $0.28 $0.26 $0.02
08/07/2024 Q2 $532.7M $543.3M $0.47 $0.44 $0.03
05/08/2024 Q1 $518.2M $515.8M $0.24 $0.30 -$0.06
02/07/2024 Q4 $499M $495.3M $0.29 $0.25 $0.04
11/01/2023 Q3 -- -- $0.37 $0.35 $0.02
08/01/2023 Q2 -- -- $0.45 $0.59 -$0.14
05/01/2023 Q1 -- -- $0.39 $0.34 $0.05
02/06/2023 Q4 -- -- $0.27 $0.22 $0.05
10/31/2022 Q3 -- -- $0.34 $0.37 -$0.03
08/01/2022 Q2 -- -- $0.50 $0.46 $0.04
05/02/2022 Q1 -- -- $0.42 $0.43 -$0.01
02/07/2022 Q4 -- -- $0.37 $0.38 -$0.01
11/01/2021 Q3 -- -- $0.43 $0.37 $0.06
08/02/2021 Q2 -- -- $0.41 $0.40 $0.01
05/03/2021 Q1 -- -- $0.26 $0.20 $0.06
02/01/2021 Q4 -- -- $0.23 $0.09 $0.14
11/02/2020 Q3 -- -- -$0.26 $0.05 -$0.31
08/03/2020 Q2 -- -- -$0.11 $0.12 -$0.23
05/04/2020 Q1 -- -- $0.03 $0.29 -$0.26
02/03/2020 Q4 -- -- -$0.07 $0.20 -$0.27
11/04/2019 Q3 -- -- $0.08 $0.17 -$0.09
08/05/2019 Q2 -- -- $0.74 $0.85 -$0.11
05/06/2019 Q1 -- -- $0.82 $0.79 $0.03
02/04/2019 Q4 -- -- $0.66 $0.68 -$0.02
11/05/2018 Q3 -- -- $0.68 $0.65 $0.03
08/06/2018 Q2 -- -- $0.83 -- --
05/03/2018 Q1 -- -- $0.61 -- --
01/26/2018 Q4 -- -- $0.50 -- --
11/02/2017 Q3 -- -- $0.48 -- --
08/03/2017 Q2 -- -- $0.30 -- --
04/26/2017 Q1 -- -- $0.48 -- --
02/02/2017 Q4 -- -- $0.09 -- --
10/27/2016 Q3 -- -- -$0.27 -- --
08/02/2016 Q2 -- -- -$0.83 -- --
05/03/2016 Q1 -- -- $0.20 -- --
02/03/2016 Q4 -- -- -$2.12 -- --
11/03/2015 Q3 -- -- -$0.08 -- --
07/30/2015 Q2 -- -- $0.26 -- --
05/05/2015 Q1 -- -- -$0.58 -- --

Kennametal Earnings Questions

  • How Much did Kennametal Generate in Revenue Last Quarter?

    Kennametal reported $482.1M worth of top line sales in its most recent quarter.

  • Did Kennametal Beat Earnings Last Quarter?

    Kennametal announced earnings per share of $0.23 which represents a miss of analyst forecast a $0.26 per share.

  • Is Kennametal Profitable?

    Kennametal reported $145M that represents $1.85 per share over the last quarter.

  • What is the Analyst Consensus for Kennametal EPS Next Year?

    Kennametal's earnings are forecast to decrease from $1.37 per share to $1.44 per share next year representing a decrease of -14.73%.

  • When is Kennametal's Earnings Date?

    Kennametal's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 24

Regencell Bioscience Holdings [RGC] is down 20.83% over the past day.

Sell
36
VMI alert for Mar 24

Valmont Industries [VMI] is up 4.84% over the past day.

Buy
61
ALNY alert for Mar 24

Alnylam Pharmaceuticals [ALNY] is up 5.26% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock